Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1983 Feb;71(2):395–399. doi: 10.1172/JCI110782

Fluorescence of experimental atheromatous plaques with hematoporphyrin derivative.

J R Spears, J Serur, D Shropshire, S Paulin
PMCID: PMC436880  PMID: 6822671

Abstract

Fluorescence of hematoporphyrin derivative (HPD) has been used clinically to localize malignant neoplasms because of its selective accumulation in these tissues. We tested the hypothesis that HPD may also be selectively concentrated within atheromatous plaques. 48 h after HPD injection in a variety of species, selective fluorescence of atheromatous plaques of the aorta was seen in each animal (rabbits and Patas monkey) exhibiting such lesions. No fluorescence could be demonstrated in aortic segments free of atheromatous involvement. Since the efficacy of photodynamic destruction of malignant tumors with HPD has been demonstrated in clinical studies, the observations of the present study may have therapeutic implications in atheromatosis.

Full text

PDF
395

Images in this article

396Image
on p.396
397Image
on p.397
397Image
on p.397

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong M. L., Megan M. B., Warner E. D. Intimal thickening in normocholesterolemic rhesus monkeys fed low supplements of dietary cholesterol. Circ Res. 1974 Apr;34(4):447–454. doi: 10.1161/01.res.34.4.447. [DOI] [PubMed] [Google Scholar]
  2. Benditt E. P., Benditt J. M. Evidence for a monoclonal origin of human atherosclerotic plaques. Proc Natl Acad Sci U S A. 1973 Jun;70(6):1753–1756. doi: 10.1073/pnas.70.6.1753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cortese D. A., Kinsey J. H., Woolner L. B., Payne W. S., Sanderson D. R., Fontana R. S. Clinical application of a new endoscopic technique for detection of in situ bronchial carcinoma. Mayo Clin Proc. 1979 Oct;54(10):635–641. [PubMed] [Google Scholar]
  4. Dayton S., Hashimoto S., Pearce M. L. Influence of a diet high in unsaturated fat upon composition of arterial tissue and atheromata in man. Circulation. 1965 Dec;32(6):911–924. doi: 10.1161/01.cir.32.6.911. [DOI] [PubMed] [Google Scholar]
  5. Deupree R. H., Fields R. I., McMahan C. A., Strong J. P. Atherosclerotic lesions and coronary heart disease. Key relationships in necropsied cases. Lab Invest. 1973 Feb;28(2):252–262. [PubMed] [Google Scholar]
  6. Diamond I., Granelli S. G., McDonagh A. F., Nielsen S., Wilson C. B., Jaenicke R. Photodynamic therapy of malignant tumours. Lancet. 1972 Dec 2;2(7788):1175–1177. doi: 10.1016/s0140-6736(72)92596-2. [DOI] [PubMed] [Google Scholar]
  7. Dougherty T. J., Grindey G. B., Fiel R., Weishaupt K. R., Boyle D. G. Photoradiation therapy. II. Cure of animal tumors with hematoporphyrin and light. J Natl Cancer Inst. 1975 Jul;55(1):115–121. doi: 10.1093/jnci/55.1.115. [DOI] [PubMed] [Google Scholar]
  8. Dougherty T. J., Kaufman J. E., Goldfarb A., Weishaupt K. R., Boyle D., Mittleman A. Photoradiation therapy for the treatment of malignant tumors. Cancer Res. 1978 Aug;38(8):2628–2635. [PubMed] [Google Scholar]
  9. Dougherty T. J., Lawrence G., Kaufman J. H., Boyle D., Weishaupt K. R., Goldfarb A. Photoradiation in the treatment of recurrent breast carcinoma. J Natl Cancer Inst. 1979 Feb;62(2):231–237. [PubMed] [Google Scholar]
  10. Gomer C. J., Dougherty T. J. Determination of [3H]- and [14C]hematoporphyrin derivative distribution in malignant and normal tissue. Cancer Res. 1979 Jan;39(1):146–151. [PubMed] [Google Scholar]
  11. Gregorie H. B., Jr, Horger E. O., Ward J. L., Green J. F., Richards T., Robertson H. C., Jr, Stevenson T. B. Hematoporphyrin-derivative fluorescence in malignant neoplasms. Ann Surg. 1968 Jun;167(6):820–828. doi: 10.1097/00000658-196806000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kessel D. Components of hematoporphyrin derivatives and their tumor-localizing capacity. Cancer Res. 1982 May;42(5):1703–1706. [PubMed] [Google Scholar]
  13. LIPSON R. L., BALDES E. J., OLSEN A. M. FURTHER EVALUATION OF THE USE OF HEMATOPORPHYRIN DERIVATIVE AS A NEW AID FOR THE ENDOSCOPIC DETECTION OF MALIGNANT DISEASE. Dis Chest. 1964 Dec;46:676–679. [PubMed] [Google Scholar]
  14. LIPSON R. L., BALDES E. J., OLSEN A. M. The use of a derivative of hematoporhyrin in tumor detection. J Natl Cancer Inst. 1961 Jan;26:1–11. [PubMed] [Google Scholar]
  15. LIPSON R. L., PRATT J. H., BALDES E. J., DOCKERTY M. B. HEMATOPORPHYRINE DERIVATIVE FOR DETECTION OF CERVICAL CANCER. Obstet Gynecol. 1964 Jul;24:78–84. [PubMed] [Google Scholar]
  16. PECK G. C., MACK H. P., HOLBROOK W. A., FIGGE F. H. Use of hematoporphyrin fluorescence in biliary and cancer surgery. Am Surg. 1955 Mar;21(3):181–188. [PubMed] [Google Scholar]
  17. Pearson T. A., Wang B. A., Solez K., Heptinstall R. H. Clonal characteristics of fibrous plaques and fatty streaks from human aortas. Am J Pathol. 1975 Nov;81(2):379–387. [PMC free article] [PubMed] [Google Scholar]
  18. Profio A. E., Doiron D. R. A feasibility study of the use of fluorescence bronchoscopy for localization of small lung tumours. Phys Med Biol. 1977 Sep;22(5):949–957. doi: 10.1088/0031-9155/22/5/014. [DOI] [PubMed] [Google Scholar]
  19. RASSMUSSEN-TAXDAL D. S., WARD G. E., FIGGE F. H. Fluorescence of human lymphatic and cancer tissues following high doses of intravenous hematoporphyrin. Cancer. 1955 Jan-Feb;8(1):78–81. doi: 10.1002/1097-0142(1955)8:1<78::aid-cncr2820080109>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  20. Ross R., Glomset J. Studies of primate arterial smooth muscle cells in relation to atherosclerosis. Adv Exp Med Biol. 1974;43(0):265–279. doi: 10.1007/978-1-4684-3243-5_13. [DOI] [PubMed] [Google Scholar]
  21. Smith E. B., Evans P. H., Downham M. D. Lipid in the aortic intima. The correlation of morphological and chemical characteristics. J Atheroscler Res. 1967 Mar-Apr;7(2):171–186. doi: 10.1016/s0368-1319(67)80079-6. [DOI] [PubMed] [Google Scholar]
  22. Stary H. C. Proliferation of arterial cells in atherosclerosis. Adv Exp Med Biol. 1974;43(0):59–81. doi: 10.1007/978-1-4684-3243-5_4. [DOI] [PubMed] [Google Scholar]
  23. Tejada C., Strong J. P., Montenegro M. R., Restrepo C., Solberg L. A. Distribution of coronary and aortic atherosclerosis by geographic location, race, and sex. Lab Invest. 1968 May;18(5):509–526. [PubMed] [Google Scholar]
  24. WHEREAT A. F. LIPID BIOSYNTHESIS IN AORTIC INTIMA FROM NORMAL AND CHOLESTEROL-FED RABBITS. J Atheroscler Res. 1964 May-Jun;4:272–282. doi: 10.1016/s0368-1319(64)80009-0. [DOI] [PubMed] [Google Scholar]
  25. WINKELMAN J., RASMUSSEN-TAXDAL D. S. Quantitative determination of porphyrin uptake by tumor tissue following parenteral administration. Bull Johns Hopkins Hosp. 1960 Oct;107:228–233. [PubMed] [Google Scholar]
  26. Weishaupt K. R., Gomer C. J., Dougherty T. J. Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. Cancer Res. 1976 Jul;36(7 Pt 1):2326–2329. [PubMed] [Google Scholar]
  27. Winkelman J., Slater G., Grossman J. The concentration in tumor and other tissues of parenterally administered tritium- and 14-C-labeled tetraphenylporphinesulfonate. Cancer Res. 1967 Nov;27(11):2060–2064. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES